Evidence map›Paper›PMID 28663583›Full record

ArticleScientific reports2017

Aminoglycoside-driven biosynthesis of selenium-deficient Selenoprotein P.

Kostja Renko, Janine Martitz, Sandra Hybsier, Bjoern Heynisch, Linn Voss, Robert A Everley, Steven P Gygi, Mette Stoedter, Monika Wisniewska, Josef Köhrle and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Kostja RenkoInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany.
Janine MartitzInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany.
Sandra HybsierInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany.
Bjoern HeynischInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany.
Linn VossInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany.
Robert A EverleyDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Mette StoedterInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany.
Monika WisniewskaInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany.
Josef KöhrleInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany.
Vadim N GladyshevDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Lutz SchomburgInstitut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, D-13353, Germany. lutz.schomburg@charite.de.ORCID 0000-0001-9445-1555
Charité - Universitätsmedizin Berlin · DEHarvard University · USBrigham and Women's Hospital · US

Funding

IDENTITY OF TERMINATOR AND SELENOCYSTEINE UGA CODONSR01GM061603 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2000 to 2016
$4.0M
Functions of thioredoxin reductases and their targetsR37GM065204 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2011 to 2020
$4.0M
Functions of Mammalian Thioredoxin ReductasesR01GM065204 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2002 to 2009
$2.2M
NIGMS NIH HHS R01 GM061603NIGMS NIH HHS R01 GM065204NIGMS NIH HHS R37 GM065204
6 · The paper itself

Abstract

Selenoprotein biosynthesis relies on the co-translational insertion of selenocysteine in response to UGA codons. Aminoglycoside antibiotics interfere with ribosomal function and may cause codon misreading. We hypothesized that biosynthesis of the selenium (Se) transporter selenoprotein P (SELENOP) is particularly sensitive to antibiotics due to its ten in frame UGA codons. As liver regulates Se metabolism, we tested the aminoglycosides G418 and gentamicin in hepatoma cell lines (HepG2, Hep3B and Hepa1-6) and in experimental mice. In vitro, SELENOP levels increased strongly in response to G418, whereas expression of the glutathione peroxidases GPX1 and GPX2 was marginally affected. Se content of G418-induced SELENOP was dependent on Se availability, and was completely suppressed by G418 under Se-poor conditions. Selenocysteine residues were replaced mainly by cysteine, tryptophan and arginine in a codon-specific manner. Interestingly, in young healthy mice, antibiotic treatment failed to affect Selenop biosynthesis to a detectable degree. These findings suggest that the interfering activity of aminoglycosides on selenoprotein biosynthesis can be severe, but depend on the Se status, and other parameters likely including age and general health. Focused analyses with aminoglycoside-treated patients are needed next to evaluate a possible interference of selenoprotein biosynthesis by the antibiotics and elucidate potential side effects.

Indexed as

Amino AcidsAminoglycosidesAnimalsCell Line, TumorChromatography, LiquidCodon, TerminatorGene ExpressionGentamicinsHepatocytesHumansMaleMiceProtein BiosynthesisSeleniumSelenoprotein PTandem Mass SpectrometryAmino AcidsAminoglycosidesCodon, TerminatorGentamicinsSeleniumSelenoprotein P

Identifiers

PMID28663583
PMCPMC5491492
OpenAlexW2686528966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.